INS and type 2 diabetes mellitus: UCSC-EXOs could increase insulin sensitivity by increasing the activation of insulin/AKT signaling pathway and inhibiting the secretion of proinflammatory cytokines like TNF-α, which could reverse insulin resistance in T2DM (96).